Gruenwald V, Graeven U, Ivanyi P, Dietz A, Hahn D, Hackenberg S, Kasper S, Fietkau R, Moulin JC, Pink D, Schaaf M, Klinghammer K (2021)
Publication Type: Conference contribution
Publication year: 2021
Publisher: ELSEVIER
City/Town: AMSTERDAM
Pages Range: S807-S808
Conference Proceedings Title: ANNALS OF ONCOLOGY
DOI: 10.1016/j.annonc.2021.08.1322
APA:
Gruenwald, V., Graeven, U., Ivanyi, P., Dietz, A., Hahn, D., Hackenberg, S.,... Klinghammer, K. (2021). Results of a randomized phase II study comparing pembrolizumab with methotrexate in elderly, frail or cisplatin-ineligible patients with relapsed or metastatic squamous cell carcinoma of the head and neck (RM-SCCHN) (ELDORANDO-AIO-KHT-0115). In ANNALS OF ONCOLOGY (pp. S807-S808). AMSTERDAM: ELSEVIER.
MLA:
Gruenwald, V., et al. "Results of a randomized phase II study comparing pembrolizumab with methotrexate in elderly, frail or cisplatin-ineligible patients with relapsed or metastatic squamous cell carcinoma of the head and neck (RM-SCCHN) (ELDORANDO-AIO-KHT-0115)." Proceedings of the ANNALS OF ONCOLOGY AMSTERDAM: ELSEVIER, 2021. S807-S808.
BibTeX: Download